Rallybio RLYB
NASDAQ RLYB
$16.95 +0.35 (+2.11%)
As of: Aug 21, 2026 · 10:50 AM EDT

Rallybio (RLYB) Net Margin (2024 - 2026)

Rallybio (RLYB) posted Net Margin of 3904.72% for Q1 2026, down 48.13% sequentially from 2636.04% in Q4 2025, and up 27075.0% YoY from N/an in Q1 2025.

Rallybio (RLYB) Net Margin (2024 - 2026) Analysis & Trends

Rallybio has reported Net Margin for 3 years, with the latest figure at 3904.72% in Q1 2026.

  • Quarterly Net Margin rose 27075.0% year-over-year to 3904.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 877.62% (up 455209.0% YoY) and the FY2025 annual result came in at 944.52%, up 778755.0% from the prior year.
  • Net Margin declined to 3904.72% in Q1 2026 per RLYB's latest filing, from 2636.04% in the prior quarter.
  • Over five years, Net Margin peaked at 7554.72% in Q3 2025 and troughed at 27931.58% in Q4 2024.
  • A 3-year average of 5552.94% and a median of 4040.09% in 2025 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2025 and 2026: Net Margin surged 2529554 bps in 2025, then jumped 27075 bps in 2026.
  • Over 3 years, Net Margin stood at 27931.58% in 2024, then jumped by 91 bps to 2636.04% in 2025, then slumped by 48 bps to 3904.72% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 3904.72%, 2636.04%, and 7554.72% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.81 Bn 131.96 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 86.56 Bn 78.56 Bn 3.93 Bn 30.23%
3 Argenx Se 65.72 Bn 60.53 Bn 1.37 Bn 31.16%
4 Moderna 58.75 Bn 53.61 Bn 52.00 Mn -539.31%
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.76 Bn 28.45 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.59 Bn 10.19 Bn 668.28 Mn -16.51%
8 Insmed 27.63 Bn 26.47 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.24 Bn 26.40 Bn - 12.09%
10 Rallybio 96.60 Mn 96.60 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,904.72%
Dec 31, 2025 -2,636.04%
Sep 30, 2025 7,554.72%
Jun 30, 2025 -4,441.51%
Mar 31, 2025 -4,175.47%
Dec 31, 2024 -27,931.58%
Sep 30, 2024 -3,621.74%
Jun 30, 2024 -5,267.22%